What Is H-PDRN and How Does It Support Hair Growth?

What Is H-PDRN and Why Does It Happen?

H-PDRN refers to a formulation based on high-purity polydeoxyribonucleotide (PDRN), a class of DNA-derived fragments that has been studied for regenerative and tissue-supporting applications. In aesthetic medicine, PDRN is commonly positioned as a bioactive ingredient intended to support skin and tissue recovery rather than simply provide physical volume.

When applied to hair and scalp protocols, the rationale is different from that of a traditional dermal filler. The objective is not to add structural volume to the scalp but to create a more supportive microenvironment around the hair follicles.

Hair growth is controlled by a complex follicular cycle involving anagen, catagen, and telogen phases. Follicular activity can be influenced by genetics, hormones, inflammation, aging, nutritional factors, systemic conditions, and mechanical stress. Androgenetic alopecia, for example, involves progressive follicular miniaturization, while other forms of hair loss may be associated with autoimmune activity, stress, illness, or traction. The American Academy of Dermatology emphasizes that identifying the underlying cause is an important first step before selecting treatment.

From a regenerative perspective, PDRN has attracted interest because studies suggest that it can influence pathways associated with tissue repair, angiogenesis, and cellular activity. A 2025 prospective study involving 28 patients with androgenetic alopecia reported improvements in hair diameter and hair density following four polynucleotide injection sessions performed at four-week intervals. The researchers proposed that increased angiogenesis and anti-apoptotic effects may contribute to the observed results.

Earlier research also evaluated PDRN injections in female pattern hair loss. In one study, patients receiving PDRN injections demonstrated improvements in mean hair count and hair thickness compared with baseline measurements. The study reported a 17.9% improvement in mean hair count and a 13.5% improvement in mean hair thickness in the PDRN-only group.

These findings are encouraging, but they should not be interpreted as evidence that PDRN is a universal replacement for established hair-loss therapies. For professional clinics, the more appropriate positioning is as a potentially complementary regenerative treatment within a medically appropriate hair-management protocol.

How Does H-PDRN Support Hair Growth? Understanding the Difference from Traditional Hair Growth Serums

In the professional medical aesthetics industry, H-PDRN is not a hair growth serum in the traditional sense. The primary distinction lies in the method of application and the underlying mechanism of action: traditional hair growth serums are typically applied topically to the scalp surface, whereas H-PDRN is designed for professional scalp and hair care. It utilizes regenerative medicine mechanisms to penetrate the dermal layer of the scalp, thereby supporting the scalp and the microenvironment surrounding the hair follicles.

It is crucial for clinics developing hair treatment product lines to understand this distinction. H-PDRN is better suited for integration into professional hair care protocols—such as specialized scalp treatments, mesotherapy, or microneedling—where it targets the scalp microenvironment to foster hair follicle health.

Therefore, the core function of PDRN in hair care is not merely to "stimulate hair growth," but rather to improve the tissue environment surrounding the scalp and hair follicles, thereby creating optimal conditions for healthy hair growth.

The scientific rationale behind using PDRN for hair care can be understood through the following aspects:

1. Supporting tissue regeneration

PDRN has been studied for its role in tissue repair and cellular recovery. In the scalp, maintaining a healthy tissue environment may be relevant to the normal functioning of hair follicles.

2. Supporting angiogenesis

Hair follicles require an adequate supply of oxygen and nutrients. Research into polynucleotides suggests potential effects on angiogenesis, which may help explain the interest in PDRN for regenerative scalp applications. The 2025 androgenetic alopecia study specifically proposed angiogenic mechanisms as one possible contributor to treatment outcomes.

3. Supporting the follicular microenvironment

Hair follicle activity is influenced by surrounding dermal and vascular structures. Rather than directly "forcing" hair growth, regenerative approaches aim to improve conditions that may support follicular function.

4. Potential anti-inflammatory and anti-apoptotic effects

Inflammation and cellular stress can negatively affect tissue homeostasis. Research into polynucleotides has identified pathways involving inflammatory modulation and cell survival, providing part of the scientific rationale for their use in regenerative medicine.

For clinics looking to expand their injectable hair portfolio, an H-PDRN hair growth serum can therefore be positioned within a broader professional scalp-care strategy rather than marketed as a conventional filler.

Importantly, treatment should be based on appropriate patient assessment. The AAD notes that hair loss may have many causes and that treatment selection depends on the diagnosis. American Academy of Dermatology: Hair Loss Diagnosis and Treatment

Treatment Approach: What to Expect？

For clinics considering H-PDRN or PDRN-based scalp treatments, a structured protocol is important for both patient management and treatment consistency.

Step 1: Assess the type and severity of hair loss

Before an injectable protocol is considered, practitioners should evaluate the patient's pattern of hair loss, duration, scalp condition, medical history, medications, and relevant risk factors.

Depending on the presentation, examination may include scalp inspection, dermoscopy, laboratory testing, or referral for further diagnostic assessment. This is particularly important because hereditary, inflammatory, autoimmune, nutritional, hormonal, and traction-related hair loss may require different treatment strategies.

Step 2: Establish realistic treatment goals

H-PDRN should be positioned as a regenerative or supportive approach rather than a guaranteed hair-regrowth solution.

For clinic communication, appropriate goals may include supporting scalp condition, improving the appearance of hair density over time, and incorporating regenerative technology into a comprehensive hair-management program.

Step 3: Select an appropriate formulation

Product composition, concentration, purity, sterility, packaging, and intended route of administration are important considerations for professional buyers.

An OTESALY H-PDRN injection is designed for professional aesthetic applications involving PDRN-based hair and scalp care. Clinics and distributors should always follow the manufacturer's product documentation, local regulations, and professional-use requirements.

Step 4: Apply the professional scalp protocol

Depending on the product's approved or intended use, practitioners may incorporate the formulation into a scalp mesotherapy or injection protocol. Treatment depth, injection technique, treatment intervals, and total number of sessions should be determined by a qualified medical professional according to the product's instructions and the patient's clinical needs.

A polynucleotide scalp injection approach can be considered as part of a broader professional mesotherapy portfolio.

Step 5: Monitor progress over time

Hair biology changes gradually. Clinics should establish consistent documentation methods, such as standardized photographs, dermoscopic evaluation, and appropriate hair-density assessments.

This is particularly important when introducing newer regenerative technologies because objective follow-up allows practitioners to evaluate whether a protocol is producing meaningful clinical changes.

Step 6: Consider combination strategies when clinically appropriate

Hair restoration increasingly involves multimodal treatment rather than reliance on a single ingredient or procedure. Depending on diagnosis and patient suitability, practitioners may consider combining established medical treatments with regenerative approaches.

For example, a PDRN hair regrowth treatment can be positioned within a broader hair-management program rather than as an isolated solution.

For clinics building a commercial treatment portfolio, this also creates opportunities to offer different protocols for different patient profiles. OTESALY's meso hair loss treatment range can support clinics seeking additional professional mesotherapy options.